Considering the biologic differences of each tumor entity that may result in various levels of CXCR4 expression, it is necessary to study the CXCR4 expression with [68Ga]pentixafor PET to help better select the patient for CXCR4-directed imaging and personalized therapy in future clinical applications. The gene discussed is CXCR4; the disease is neoplasm.